Related references
Note: Only part of the references are listed.COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors
Melissa K. Siebach et al.
PEDIATRIC PULMONOLOGY (2021)
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
Mayme Marshall et al.
PEDIATRICS (2021)
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform
Elizabeth J. Williamson et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Lyudmyla Kompaniyets et al.
JAMA NETWORK OPEN (2021)
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
Giuseppe Calcaterra et al.
PEDIATRIC REPORTS (2021)
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
Noele P. Nelson et al.
MMWR RECOMMENDATIONS AND REPORTS (2020)
Trends in Off-Label Drug Use in Ambulatory Settings: 2006-2015
Divya Hoon et al.
PEDIATRICS (2019)
Off-Label Use of Drugs in Children
Daniel A. C. Frattarelli et al.
PEDIATRICS (2014)
Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care
Tewodros Eguale et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Off-label use of medicines: consensus recommendations for evaluating appropriateness
Madlen Gazarian et al.
MEDICAL JOURNAL OF AUSTRALIA (2006)